ALXN
Alexion Pharmaceuticals Inc
Price:  
182.50 
USD
Volume:  
15,135,400.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alexion WACC - Weighted Average Cost of Capital

The WACC of Alexion Pharmaceuticals Inc (ALXN) is 7.8%.

The Cost of Equity of Alexion Pharmaceuticals Inc (ALXN) is 8.10%.
The Cost of Debt of Alexion Pharmaceuticals Inc (ALXN) is 4.25%.

Range Selected
Cost of equity 6.20% - 10.00% 8.10%
Tax rate 10.60% - 18.70% 14.65%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.1% - 9.6% 7.8%
WACC

Alexion WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 4.2% 5.2%
Adjusted beta 0.72 1.12
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 10.00%
Tax rate 10.60% 18.70%
Debt/Equity ratio 0.07 0.07
Cost of debt 4.00% 4.50%
After-tax WACC 6.1% 9.6%
Selected WACC 7.8%